ConductScience.org, home

Paper7929454

N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.

Platt FM and 4 others. J Biol Chem, 1994. Cited by 143 papers, by iCite.

Cite this record

ConductScience Library. N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing. Papers, record 7929454. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7929454

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
N-butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing.
PubMed
Journal
J Biol Chem
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
143
iCite
Relative citation ratio, by iCite
3.95
iCite
Revised in PubMed
2021-02-12
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Platt FMF M
2Neises GRG R
3Karlsson GBG B
4Dwek RAR A
5Butters TDT D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
1-DeoxynojirimycinMajor topic
GlycolipidsMajor topic
OligosaccharidesMajor topic
Animals
Cells, Cultured
Disease Models, Animal
Gaucher Disease
Glucosylceramidase
Glucosyltransferases
Humans
Mice
Structure-Activity Relationship
alpha-Glucosidases

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00194649Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)Background

Source ClinicalTrials.gov

Download CSV of trials

Cited by48

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.

PMIDTitleJournalYearIn PapersSource
42353206Off-Target Binding of Miglustat to Glycogen Debranching Enzyme.Int J Mol Sci2026https://conductscience.org/library/papers/42353206PubMed
38737101Therapeutic developments for neurodegenerative GM1 gangliosidosis.Front Neurosci2024https://conductscience.org/library/papers/38737101PubMed
37622990Cholera intoxication of human enteroids reveals interplay between decoy and functional glycoconjugate ligands.Glycobiology2023https://conductscience.org/library/papers/37622990PubMed
34445564Myelin Defects in Niemann-Pick Type C Disease: Mechanisms and Possible Therapeutic Perspectives.Int J Mol Sci2021https://conductscience.org/library/papers/34445564PubMed
33304924CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges.Front Mol Biosci2020https://conductscience.org/library/papers/33304924PubMed
32768411Iminosugars: A host-targeted approach to combat Flaviviridae infections.Antiviral Res2020https://conductscience.org/library/papers/32768411PubMed
32219518The pharmacological chaperone N-n-butyl-deoxygalactonojirimycin enhances β-galactosidase processing and activity in fibroblasts of a patient with infantile GM1-gangliosidosis.Hum Genet2020https://conductscience.org/library/papers/32219518PubMed
32083331Developments in the treatment of Fabry disease.J Inherit Metab Dis2020https://conductscience.org/library/papers/32083331PubMed
30917945Approaches for probing and evaluating mammalian sphingolipid metabolism.Anal Biochem2019https://conductscience.org/library/papers/30917945PubMed
30060815Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.Adv Cancer Res2018https://conductscience.org/library/papers/30060815PubMed
28975712Structure-Activity Studies of N-Butyl-1-deoxynojirimycin (NB-DNJ) Analogues: Discovery of Potent and Selective Aminocyclopentitol Inhibitors of GBA1 and GBA2.ChemMedChem2017https://conductscience.org/library/papers/28975712PubMed
28088251Lucerastat, an iminosugar with potential as substrate reduction therapy for glycolipid storage disorders: safety, tolerability, and pharmacokinetics in healthy subjects.Orphanet J Rare Dis2017https://conductscience.org/library/papers/28088251PubMed
27916601Gaucher disease: Progress and ongoing challenges.Mol Genet Metab2017https://conductscience.org/library/papers/27916601PubMed
27638604New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones.J Neurosci Res2016https://conductscience.org/library/papers/27638604PubMed
27384562Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.Int J Mol Sci2016https://conductscience.org/library/papers/27384562PubMed
26974655Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.PLoS Negl Trop Dis2016https://conductscience.org/library/papers/26974655PubMed
26946111Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.Antiviral Res2016https://conductscience.org/library/papers/26946111PubMed
26771826Gpnmb Is a Potential Marker for the Visceral Pathology in Niemann-Pick Type C Disease.PLoS One2016https://conductscience.org/library/papers/26771826PubMed
26095364Complexity and Diversity of the Mammalian Sialome Revealed by Nidovirus Virolectins.Cell Rep2015https://conductscience.org/library/papers/26095364PubMed
25141135GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.PLoS One2014https://conductscience.org/library/papers/25141135PubMed

See all 48 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
UGCG7357PubTator's text mininghttps://conductscience.org/library/genes/7357

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7929454

GET https://conductscience.org/api/papers/v1/7929454/cited_by?page=2